Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
ID: 331858Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/331858

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-21-137.html
Timeline
    Description

    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), is inviting applications for the Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required). This funding opportunity aims to support innovative clinical trials that explore novel mechanisms of action in psychiatric treatment, emphasizing a two-phase approach where the R61 phase focuses on milestone-driven testing of target engagement, and the R33 phase extends support for comprehensive studies assessing functional outcomes and safety. The NIH plans to allocate approximately $27 million for this initiative, which is crucial for advancing scientific understanding and clinical practice in mental health. Interested applicants must submit their proposals by October 15, 2024, and can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for any inquiries regarding the funding announcement.

    Point(s) of Contact
    FBOWebmaster@OD.NIH.GOV
    Files
    Title
    Posted
    PAR-21-137-Full-Announcement.html
    PAR-21-137.html
    The National Institutes of Health (NIH) through the National Institute of Mental Health (NIMH) is soliciting applications for early-stage testing of pharmacological or device-based interventions for mental disorders via the R61/R33 funding opportunity. This program aims to bridge the gap in psychiatric treatment research, encouraging innovative clinical trials focused on unexplored mechanisms of action. The initiative supports two phases: the R61 phase emphasizes milestone-driven testing of target engagement, while the R33 phase extends support for comprehensive studies assessing functional outcomes and safety following initial success. Eligible organizations include higher education institutions, nonprofits, and various government entities, including foreign applicants. The program outlines strict requirements for designing randomized trials, incorporating objective measures of target engagement and considering safety, dosing, and participant recruitment. In total, the NIH plans to allocate approximately $27 million for projects under this funding opportunity, which encourages the exploration of novel interventions that can fulfill critical therapeutic needs in mental health, aiming to advance scientific understanding and clinical practice through rigorous study design and data sharing commitments.
    Similar Opportunities
    Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)" aimed at advancing the development of innovative brain stimulation devices for mental health treatment. This initiative seeks applications that either create novel devices or significantly enhance existing FDA-approved devices through hardware and software improvements, focusing on increased precision and effectiveness in treatment. The funding underscores the importance of multidisciplinary collaboration in neuroscience and engineering, with an emphasis on innovative approaches rather than incremental changes. Interested applicants can find more information and submit proposals by January 7, 2028, with no budget cap but a maximum project duration of five years. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-287.html.
    Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), is offering a funding opportunity for research projects aimed at evaluating the effectiveness of post-acute interventions and services for mental health conditions affecting youth, adults, and older adults. This initiative encourages clinical trials designed to assess therapeutic strategies that consolidate treatment gains, manage residual symptoms, prevent relapse, and enhance treatment adherence, with a focus on producing statistically powered studies that address chronic or relapsing mental health issues. The program emphasizes the importance of improving long-term mental health outcomes, particularly for underserved populations, and applications are open to a diverse range of eligible entities, including educational institutions and community organizations. Interested applicants should note that the deadline for submissions is January 25, 2025, and can find further details and guidelines at the provided NIH link or contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for assistance.
    Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)." This initiative aims to stimulate innovative pilot research that enhances the quality and accessibility of mental health services, particularly for underserved populations, by encouraging projects that identify factors affecting service delivery and assess new technologies without the need for clinical trials. The funding opportunity is open to a wide range of eligible applicants, including higher education institutions, nonprofits, and governmental entities, with a budget cap of $450,000 over a maximum project period of three years. Interested applicants should submit their proposals by May 7, 2025, and can find additional information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Innovative Pilot Mental Health Services Research Not Involving Clinical Trials" (R34 Clinical Trial Not Allowed) to support pilot research projects aimed at enhancing the accessibility, quality, and delivery of mental health services to diverse populations. This initiative encourages research that identifies factors affecting service utilization, develops new methodologies, and integrates large data sets, while explicitly prohibiting clinical trial proposals. With a total budget cap of $450,000 over three years, the program seeks to address health disparities and barriers within underserved groups, fostering partnerships with stakeholders to ensure practical application of findings. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov, with key deadlines starting in January 2025 and project expiration set for January 2028.
    Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), is inviting applications for the funding opportunity titled "Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes" (PAR-25-206). This initiative aims to evaluate the preliminary effectiveness of therapeutic and service delivery interventions for the post-acute management of mental health conditions, focusing on aspects such as feasibility, tolerability, acceptability, safety, and potential effectiveness. The program is crucial for advancing mental health treatment and understanding, particularly for underserved populations, by gathering data that will inform larger-scale effectiveness trials. Interested applicants can apply for grants of up to $750,000 over a three-year period, with the submission window opening on January 5, 2025, and closing on January 7, 2028. For more information, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-206.html.
    Clinical Studies of Mental Illness (Collaborative R01) (Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Clinical Studies of Mental Illness (Collaborative R01)" aimed at supporting multidisciplinary clinical studies focused on mental health, particularly in areas such as genetics, biomarkers, and various mental illnesses. This initiative encourages collaboration across multiple sites to enhance sample sizes and diversity in participant recruitment, specifically targeting health disparity populations. The program allows for a project period of up to five years with no explicit budget limits, although proposed budgets must be well justified. Interested applicants, including various educational and nonprofit institutions, should submit their applications by January 7, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. For more details, applicants can refer to the full announcement available at https://grants.nih.gov/grants/guide/pa-files/PAR-23-050.html.
    Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)." This grant aims to support innovative research utilizing invasive neural recording methods to explore the neural circuitry associated with mental health disorders, focusing on high-risk applications that address significant gaps in knowledge regarding complex moods and cognitive behaviors. The initiative seeks to bridge basic neuroscience with applied mental health interventions, encouraging diverse research teams to utilize advanced methodologies. The estimated funding amount is capped at $200,000, with applications due by January 7, 2028. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-291.html.
    Advancing Learning Health Care Research in Outpatient Mental Health Treatment Settings (R34 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing Learning Health Care Research in Outpatient Mental Health Treatment Settings (R34 Clinical Trial Optional)," aimed at enhancing the implementation and sustainability of evidence-based practices in outpatient mental health and substance use treatment settings. This initiative encourages pilot studies that focus on data-driven learning health care, particularly in Certified Community Behavioral Health Clinics (CCBHCs), with objectives including addressing health disparities and improving crisis response services. Eligible applicants include a wide range of organizations, such as higher education institutions and community-based organizations, with funding available up to $450,000 over a three-year project period. The application submission period opens on May 16, 2024, and the final deadline for applications is January 8, 2026; for further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R34 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes" grant, aimed at evaluating therapeutic and service delivery innovations for managing mental health conditions following acute treatment. Applicants are required to conduct pilot trials that assess the feasibility, acceptability, safety, and preliminary effectiveness of interventions designed to improve long-term mental health outcomes, particularly for underserved populations. This initiative underscores the importance of advancing mental health research and fostering effective care transitions beyond acute care settings. Eligible organizations can apply for funding of up to $450,000 over three years, with applications due by January 25, 2025. For further information, interested parties can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV or visit the funding announcement at http://grants.nih.gov/grants/guide/pa-files/PAR-21-211.html.
    Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Basic Experimental Studies with Humans Required)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment," aimed at encouraging clinical research to explore novel non-invasive brain stimulation (NIBS) targets for treating substance use disorders (SUD). This initiative seeks applications for exploratory and developmental studies that will identify and validate neurobiological, cognitive, and behavioral responses to NIBS, with the goal of understanding mechanisms that could lead to reduced cravings and substance use. The NIH plans to allocate $1.5 million in funding for fiscal years 2024-2026, with an award ceiling of $500,000 per project phase, and key submission dates starting December 16, 2023. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.